(19)
(11) EP 3 465 491 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
02.03.2022 Bulletin 2022/09

(45) Mention of the grant of the patent:
15.12.2021 Bulletin 2021/50

(21) Application number: 17725002.4

(22) Date of filing: 09.05.2017
(51) International Patent Classification (IPC): 
G16H 20/17(2018.01)
G16H 50/20(2018.01)
 G16H 10/40(2018.01)
G16H 40/63(2018.01)
(52) Cooperative Patent Classification (CPC):
G16H 50/20; G16H 40/63; G16H 20/17; G16H 10/40
(86) International application number:
PCT/US2017/031661
(87) International publication number:
WO 2017/209902 (07.12.2017 Gazette 2017/49)

(54)

CONTROL-TO-RANGE AGGRESSIVENESS

CONTROL-TO-RANGE-AGGRESSIVITÄT

AGRESSIVITÉ DE CONTRÔLE PAR RAPPORT À UNE PLAGE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 01.06.2016 US 201615170450

(43) Date of publication of application:
10.04.2019 Bulletin 2019/15

(73) Proprietors:
  • Roche Diabetes Care GmbH
    68305 Mannheim (DE)
    Designated Contracting States:
    DE 
  • F. Hoffmann-La Roche AG
    4070 Basel (CH)
    Designated Contracting States:
    AL AT BE BG CH CY CZ DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR 

(72) Inventors:
  • DUKE, David L.
    Fishers, Indiana 46037 (US)
  • GREENBURG, Alan
    Indianapolis, Indiana 46256 (US)
  • RINGEMANN, Christian
    D-68165 Mannheim (DE)
  • MANOHAR, Chinmay Uday
    Fishers, Indiana 46037 (US)

(74) Representative: Bittner, Thomas L. 
Boehmert & Boehmert Anwaltspartnerschaft mbB Pettenkoferstrasse 22
80336 München
80336 München (DE)


(56) References cited: : 
US-A1- 2011 313 674
US-A1- 2015 273 147
 US-A1- 2014 100 435
   
  • KOVATCHEV B P ET AL: "Symmetrization of the blood glucose measurement scale and its applications", DIABETES, AMERICAN DIABETES ASSOCIATION, ALEXANDRIA, VA, US, vol. 20, no. 11, 1 November 1997 (1997-11-01), pages 1655-1658, XP008128145, ISSN: 0149-5992, DOI: 10.2337/DIACARE.20.11.1655
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).